Scaling up and translating nanotherapy from pre-clinical work in small animal models to a clinical application is not trivial. An international team of researchers from the United States and Europe, including from the Radboudumc, published their results on translating a new nanoimmunotherapy in the journal Science Translational Medicine.
Raphaël Duivenvoorden, theme Renal disorders, together with Willem Mulder (Eindhoven University of Technology and Icahn School of Medicine at Mount Sinai in New York), Tina Binderup (University of Copenhagen) and Sherrill Fay (Icahn School of Medicine at Mount Sinai in New York) and their colleagues, developed a simvastatin-loaded high-density lipoprotein (S-HDL) – nanoparticle.
In a mouse model they showed that S-HDL nanoparticles inhibit inflammation in blood vessel walls, a process that drives atherosclerosis development. Subsequently they tested methods to scale up S-HDL nanoparticle production, a critical step needed for larger animal studies. Using advanced imaging techniques, they show that the scaled up nanoparticles exhibited anti-inflammatory effects in the blood vessels of atherosclerosis in rabbit and pig models, thereby reducing atherosclerosis.
This study highlights the challenges posed by scaling a nanotherapy for use in larger animal models and strategies to overcome these challenges.
Related news items
RIMLS award ceremony proudly presenting the winners16 January 2020
Several RIMLS researchers received an award and bonus during the New Year's drinks. See all photo's and the ENABLE aftermovie.read more
Stofwisselkracht grant for Daan Panneman and Richard Rodenburg16 January 2020
Daan Panneman & Richard Rodenburg have been awarded a Stofwisselkracht grant for their proposal “CRISPR/Cas9 knock-in complementation in fibroblasts of mitochondrial disease patients”. Together with Omar Tutakhel & Jan Smeitink they will investigate the possibility of using CRISPR/Cas9 knock-in.read more
The PRIDE Study Evaluation of online methods of data collection16 January 2020
In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study.read more
Laparoscopy reduces the number of adhesions but it is still too high14 January 2020
Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by RIHS researcher Richard ten Broek and colleagues.read more
Rubicon Grant for Marieke Klein14 January 2020
DCMN researcher Marieke Klein, theme Neurodevelopmental disorders, received a Rubicon Grant from the Dutch Organisation for Scientific Research (NWO). The Rubicon program gives young, highly promising researchers the opportunity to gain international research experience.read more